Canada markets closed

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.4400-0.0800 (-5.26%)
At close: 04:00PM EDT
1.3700 -0.07 (-4.86%)
After hours: 05:19PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.5200
Bid1.4100 x 1300
Ask1.4300 x 800
Day's Range1.3301 - 1.5400
52 Week Range1.3300 - 25.5900
Avg. Volume239,509
Market Cap37.781M
Beta (5Y Monthly)1.51
PE Ratio (TTM)N/A
EPS (TTM)-4.0020
Earnings DateAug 10, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.10
  • Zacks

    Dr. Reddy's (RDY) Q4 Earnings Decline Y/Y, Sales Increase

    Dr. Reddy's (RDY) earnings decline while sales grow year over year in fourth-quarter fiscal 2022.

  • GlobeNewswire

    Applied Therapeutics to Present at the UBS Global Healthcare Conference

    NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will participate in a fireside chat at the UBS Global Healthcare Conference on Wednesday, March 25, 2022 at 10:45 a.m. ET in New York. Webcast information for this event will be accessible on the Events page under the Inv

  • Zacks

    Ultragenyx (RARE) Acquires Rights of AAV Gene Therapy Candidate

    Ultragenyx (RARE) signs an exclusive license agreement with Abeona Therapeutics to acquire the latter's gene therapy candidate, ABO-102 (now UX111), for treating Sanfilippo syndrome type A.